Ham, I take your point. The market would still remain fragmented. We could give Teva the edge by modifying the settlement. Our parents would still be vacated. However If we did this the other generic companies would win nothing by winning. If we go down in this fight they win nothing. This suggest to me they need to come to the table.
Market Data 
Markets 
AI
